Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551
Date first appeared online | 31/05/2017 |
DOI | 10.1080/03007995.2017.1336432 |
Authors | Stephens J. |
Journal Name | Current Medical Research and Opinion |
Volume |
Documents
- 34694.pdf , Book, 12 month embargo.